Table 6.
Baseline characteristics of the study population, Miami Heart Study.
| MiHeart Study (N = 2459) | |
|---|---|
| Demographics | |
| Age, years | 53.35 (6.78) |
| Women | 1198 (48.7%) |
| Race | |
| White | 2104 (85.6%) |
| Black | 94 (3.8%) |
| Asian | 74 (3%) |
| Other | 186 (7.6%) |
| Ethnicity | |
| Hispanic/Latino | 1166 (47.4%) |
| Not Hispanic/Latino | 1255 (51%) |
| Other cardiovascular risk factors | |
| Body mass index, kg/m2 | 28.45 (5.29) |
| Body mass index categories | |
| Normal weight | 679 (27.6%) |
| Overweight | 991 (40.3%) |
| Obesity | 789 (32.1%) |
| Family history of CVD | 707 (28.8%) |
| Family history of premature CVD | 185 (7.5%) |
| Tobacco use | |
| Current smoker | 75 (3.1%) |
| Former smoker | 602 (24.5%) |
| Never smoker | 1782 (72.5%) |
| Diabetes | 175 (7.1%) |
| Hypertension | 808 (32.9%) |
| Hyperlipidemia | 331 (13.5%) |
| Dyslipidemia | 731 (29.7%) |
| Baseline medication use | |
| Statin use | 371 (15.1%) |
| Aspirin use | 569 (23.1%) |
| Estimated ASCVD risk | |
| 10-Year Estimated ASCVD risk,*% | 3.96 (4.16) |
*Using the Pooled Cohort Equations.
Results are presented as either number (%) or mean (standard deviation).
Abbreviations: ASCVD = atherosclerotic cardiovascular disease; CVD = cardiovascular disease.